JP2016510998A5 - - Google Patents

Download PDF

Info

Publication number
JP2016510998A5
JP2016510998A5 JP2016501146A JP2016501146A JP2016510998A5 JP 2016510998 A5 JP2016510998 A5 JP 2016510998A5 JP 2016501146 A JP2016501146 A JP 2016501146A JP 2016501146 A JP2016501146 A JP 2016501146A JP 2016510998 A5 JP2016510998 A5 JP 2016510998A5
Authority
JP
Japan
Prior art keywords
mouse
polypeptide
human
item
nucleotide sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016501146A
Other languages
English (en)
Japanese (ja)
Other versions
JP6456351B2 (ja
JP2016510998A (ja
Filing date
Publication date
Priority claimed from US13/793,812 external-priority patent/US9591835B2/en
Application filed filed Critical
Priority claimed from PCT/US2014/023076 external-priority patent/WO2014164640A1/en
Publication of JP2016510998A publication Critical patent/JP2016510998A/ja
Publication of JP2016510998A5 publication Critical patent/JP2016510998A5/ja
Application granted granted Critical
Publication of JP6456351B2 publication Critical patent/JP6456351B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

JP2016501146A 2013-03-11 2014-03-11 キメラ主要組織適合複合体（ｍｈｃ）クラスｉ分子を発現する遺伝子導入マウス Active JP6456351B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/793,812 US9591835B2 (en) 2011-10-28 2013-03-11 Genetically modified major histocompatibility complex animals
US13/793,812 2013-03-11
PCT/US2014/023076 WO2014164640A1 (en) 2013-03-11 2014-03-11 Transgenic mice expressing chimeric major histocompatibility complex (mhc) class i molecules

Publications (3)

Publication Number Publication Date
JP2016510998A JP2016510998A (ja) 2016-04-14
JP2016510998A5 true JP2016510998A5 (enExample) 2017-04-13
JP6456351B2 JP6456351B2 (ja) 2019-01-23

Family

ID=50513441

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016501146A Active JP6456351B2 (ja) 2013-03-11 2014-03-11 キメラ主要組織適合複合体（ｍｈｃ）クラスｉ分子を発現する遺伝子導入マウス

Country Status (8)

Country Link
EP (1) EP2967014B1 (enExample)
JP (1) JP6456351B2 (enExample)
KR (1) KR102313053B1 (enExample)
CN (1) CN105188358B (enExample)
AU (2) AU2014249150B2 (enExample)
CA (1) CA2902543A1 (enExample)
ES (1) ES2764829T3 (enExample)
WO (1) WO2014164640A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9591835B2 (en) 2011-10-28 2017-03-14 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex animals
CA2900832A1 (en) 2013-02-20 2014-08-28 Regeneron Pharmaceuticals, Inc. Mice expressing humanized t-cell co-receptors
CA2900824A1 (en) 2013-02-22 2014-08-28 Regeneron Pharmaceuticals, Inc. Mice expressing humanized major histocompatibility complex
US20150342163A1 (en) 2013-02-22 2015-12-03 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex mice
WO2016065329A1 (en) * 2014-10-24 2016-04-28 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for inducing phagocytosis of mhc class i positive cells and countering anti-cd47/sirpa resistance
WO2016065245A1 (en) 2014-10-24 2016-04-28 Incept, Llc Extra luminal scaffold
RU2732628C2 (ru) * 2015-04-06 2020-09-21 Регенерон Фармасьютикалз, Инк. Опосредованные гуманизированными т-клетками иммунные ответы у не относящихся к человеку животных
CN109456942A (zh) * 2017-09-06 2019-03-12 亘喜生物科技（上海）有限公司 通用型嵌合抗原受体t细胞制备技术
WO2020240876A1 (ja) * 2019-05-27 2020-12-03 株式会社トランスジェニック エクソンヒト化マウス
US10841728B1 (en) 2019-10-10 2020-11-17 Boomcloud 360, Inc. Multi-channel crosstalk processing
US20230072216A1 (en) * 2020-01-10 2023-03-09 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric mhc protein complex
US12376573B2 (en) 2021-03-31 2025-08-05 Regeneron Pharmaceuticals, Inc. Genetically modified mice comprising humanized cellular immune system components with improved diversity of TCRB repertoire
EP4215042A1 (en) 2022-01-21 2023-07-26 Max-Delbrück-Centrum für Molekulare Medizin A non-human mammal comprising in its genome at least two human leukocyte antigen (hla) class i alleles, methods of making such mammal and uses thereof
WO2025212991A1 (en) 2024-04-05 2025-10-09 Regeneron Pharmaceuticals, Inc. Rodent models of disease

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5489742A (en) * 1990-10-23 1996-02-06 Board Of Regents, The University Of Texas System Transgenic rats and animal models of inflammatory disease
US20020151690A1 (en) * 1997-08-12 2002-10-17 Luxemburg Alain T Purification of antigen-specific t cells
AU777952B2 (en) * 1999-04-23 2004-11-04 Pharmexa A/S Method for down-regulating IL5 activity
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
AU2002222610A1 (en) 2000-12-13 2002-06-24 Sumitomo Pharmaceuticals Company, Limited Transgenic animal expressing hla-a24 and utilization thereof
FR2827302B1 (fr) 2001-07-13 2003-10-10 Genoway Cellule et animal transgenique modelisant la presentation antigenique humaine et leurs utilisations
AU2003201093A1 (en) * 2002-01-18 2003-07-30 Inovio As Bispecific antibody dna constructs for intramuscular administration
SE0301109D0 (sv) * 2003-04-14 2003-04-14 Mallen Huang Nucleotide vaccine composition
US7663017B2 (en) * 2003-07-30 2010-02-16 Institut Pasteur Transgenic mice having a human major histocompatability complex (MHC) phenotype, experimental uses and applications
WO2006044962A1 (en) 2004-10-19 2006-04-27 Regeneron Pharmaceuticals, Inc. Method for generating an animal homozygous for a genetic modification
EP1878342A1 (en) 2006-07-13 2008-01-16 Institut Pasteur Immunodeficient mice transgenic for HLA class I and HLA class II molecules and their uses
ES2741649T3 (es) * 2011-10-28 2020-02-11 Regeneron Pharma Ratones con complejo mayor de histocompatibilidad modificado genéticamente

Similar Documents

Publication Publication Date Title
JP2014532412A5 (enExample)
JP7261772B2 (ja) ヒト化ｔ細胞補助受容体を発現するマウス
JP2018126170A5 (enExample)
JP6681939B2 (ja) ヒト化主要組織適合性遺伝子複合体を発現するマウス
JP2023174872A (ja) 非ヒト動物におけるヒト化ｔ細胞媒介性免疫応答
JP6574457B2 (ja) 遺伝子改変された主要組織適合複合体マウス
JP2016507247A5 (enExample)
AU2020204410C1 (en) Transgenic mice expressing chimeric major histocompatibility complex (mhc) class i molecules
AU2012324016B8 (en) Genetically modified major histocompatibility complex mice
JP2019068857A5 (enExample)
HK1249712A1 (en) Genetically modified major histocompatibility complex mice
JP2015523863A5 (enExample)
HRP20211455T1 (hr) Životinje s humaniziranim il-4 i il-4r alfa
RU2016143036A (ru) Не относящиеся к человеку животные, имеющие гуманизированные fc-гамма-рецепторы
KR20250077529A (ko) 인간 세포 면역계의 성분을 발현하는, 유전자적으로 변형된 마우스
BR122019026475B1 (pt) Composição e método para produzir um camundongo geneticamente modificado
HK1212859B (en) Transgenic mice expressing chimeric major histocompatibility complex (mhc) class i molecules